Inhalation Sciences Sweden AB (publ) ramps up commercial activities in the US
(Stockholm, Sweden, April 20, 2021) Inhalation Sciences (ISAB) has signed an agreement with prestigious lead generation company Cience and with Coelus Bio, a boutique CRO consulting firm specialized in inhalation drug development, to generate new leads and sales in the US. It is part of the marketing activities aimed at growing ISAB’s sales and presence in the US, a strategic goal for 2021, and becoming a clear market leader in its niche.With strengthened sales in 2020 ISAB identified expanding its marketing and sales activities as a vital strategy for 2021, aiming to expand sales in the US